China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Cenobamate in Patients with Drug-Resistant Epilepsy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135371
Registration Time: 2026/10/29
Type: Observational study
Primary Sponsor: Shandong Provincial Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341482
Published by HT Digital Content Services with permission from Health Daily Digest....